← Back to headlines
Neurogene Reports GAAP EPS of -$4.24, Exceeding Estimates
Neurogene announced its GAAP EPS at -$4.24, which surpassed analyst expectations by $0.04. The company's financial results indicate a slight beat on earnings per share.
24 Mar, 11:41 — 24 Mar, 11:41
Sources
Showing 1 of 1 sources
